Laurent Fischer
Vorstandsvorsitzender bei ADVERUM BIOTECHNOLOGIES, INC.
Vermögen: 701 475 $ am 30.06.2024
Ursprung des Netzwerks ersten Grades von Laurent Fischer
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
72
| Subsidiary | Pharmaceuticals: Major | 72 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.
60
| Subsidiary | Investment Managers | 60 |
| Public Company | Pharmaceuticals: Major | 38 | |
| Public Company | Pharmaceuticals: Major | 36 | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.
28
| Subsidiary | Biotechnology | 28 |
| Public Company | Pharmaceuticals: Major | 27 | |
dpa Deutsche Presse-Agentur GmbH
 dpa Deutsche Presse-Agentur GmbH Internet Software/ServicesTechnology Services dpa Deutsche Presse-Agentur GmbH publishes on-line news. It develops and produces multimedia news products for the Web, mobile portal, and print applications, as well as engages in managing mobile services for media companies, providing cross media services for newspapers, international still graphics, and offers picture agency services. The company was founded in 1949 and is headquartered in Hamburg, Germany.
21
| Private Company | Internet Software/Services | 21 |
| Subsidiary | Pharmaceuticals: Major | 16 | |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.
16
| Extinct | Pharmaceuticals: Major | 16 |
Ocera Therapeutics, Inc. /Old/
 Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. is a San Diego based, privately held biopharmaceutical company founded in January 2005 by Dr. Eckard Weber and Dr. Laurent Fischer. Ocera focuses on the development of novel therapeutics in the areas of liver and gastrointestinal diseases.
10
| Extinct | Pharmaceuticals: Major | 10 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
FORM Life Ventures
 FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg.
8
| Private Company | Investment Managers | 8 |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Auxeris Therapeutics, Inc.
 Auxeris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Auxeris Therapeutics, Inc. manufactures drugs for osteoporosis, bone metastasis and other bone diseases. The company was founded in 2002 and is located in St. Louis, MO
3
| Extinct | Pharmaceuticals: Major | 3 |
Lycia Therapeutics, Inc.
 Lycia Therapeutics, Inc. BiotechnologyHealth Technology Lycia Therapeutics, Inc. is a biotechnology company, which engages in the developing technology that utilizes lysosome-targeting chimeras. It uses LYTACs platform to discover and provide therapeutics that degrade extracellular and membrane-bound proteins that drive a range of difficult-to treat diseases, including cancers and autoimmune conditions. The company was founded by Carolyn R. Bertozzi in 2019 and is headquartered in San Diego, CA.
3
| Holding Company | Biotechnology | 3 |
Rxcentric, Inc.
2
| Extinct | Packaged Software | 2 |
Vytal, Inc.
 Vytal, Inc. Drugstore ChainsRetail Trade Vytal, Inc. provides medication access, adherence, and direct-to-patient consumer programs. It offers prescription assistance, patient engagement, anticipatory logistic solutions, and omni-channel platform. The company was founded Levin Scott Bechtler, Paul Cattaneo, and Robert J. Feeney Jr. in 2000 and is headquartered in San Diego, CA.
2
| Holding Company | Drugstore Chains | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Laurent Fischer
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| REPROS THERAPEUTICS INC | Pharmaceuticals: Major | President Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| DELCATH SYSTEMS, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Comptroller/Controller/Auditor | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| RENOVARO INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ABBVIE INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin Graduate Degree Undergraduate Degree Undergraduate Degree | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| University of London | College/University | Undergraduate Degree Doctorate Degree | |
| Santa Clara University | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of California, Irvine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Director/Board Member | |
| Harvard Medical School | College/University | Graduate Degree Corporate Officer/Principal | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| IMAGO BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Founder Director/Board Member | |
ATAI Life Sciences AG
 ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Founder Founder Chief Operating Officer Chief Executive Officer | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ACELYRIN, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 45 |
| Vereinigtes Königreich | 4 |
| Kanada | 2 |
| Schweiz | 2 |
| Deutschland | 2 |
Sektoral
| Health Technology | 36 |
| Consumer Services | 15 |
| Finance | 2 |
Operativ
| Director/Board Member | 549 |
| Corporate Officer/Principal | 241 |
| Independent Dir/Board Member | 184 |
| Chief Executive Officer | 109 |
| Chairman | 88 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Eckard Weber | 46 |
| Christian Angermayer | 45 |
| Patrick Heron | 42 |
| Timothy Walbert | 40 |
| Thomas Woiwode | 39 |
| Brenton Saunders | 38 |
| Ambrose Bailey | 32 |
| Michael Grey | 32 |
| Reed Tuckson | 31 |
| Michael Auerbach | 31 |
| Clarence Machado | 31 |
| Albert Cha | 30 |
| Laura Brege | 27 |
| James Sapirstein | 26 |
| Jim Scopa | 26 |
- Börse
- Insiders
- Laurent Fischer
- Unternehmensverbindungen
